Kirsten Alfheim Larsen

  • Study nurse

Kirsten will be working on our international collaborative study with Women’s College Hospital in Toronto, Canada. This study represents a significant step forward, as it will be the first large-scale, comprehensive research effort examining the outcomes of various treatments in women with hereditary breast cancer associated with BRCA1, BRCA2, PALB2, ATM, or CHEK2 mutations.